

S&P 500 to open higher? Polymarket odds reach 70% as Wall Street digests September jobs, 24-year high Treasury yields, and Iran sanctions.
You can purchase shares of Celularity (NASDAQ:CELU) through any online brokerage.
Other companies in Celularity’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Celularity has a consensus price target of $6.00.
The stock price for Celularity (NASDAQ: CELU) is $0.81 last updated October 29, 2026 at 4:51 PM EDT.
There are no upcoming dividends for Celularity.
Celularity does not have any upcoming earnings scheduled.
There is no upcoming split for Celularity.
Celularity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune...